breast cancer

Upcoming Catalysts For Exelixis And Immunogen
Seeking Alpha
Mon, 08/27/12 - 10:32 am
Exelixis
Immunogen
prostate cancer
breast cancer
Analysts: Roche's armed antibody will help drive breast cancer drug sales
Fierce Biotech
Thu, 08/23/12 - 10:24 am
Roche
breast cancer
T-DM1
Myriad Wins Patent Ruling Again
Yahoo/Zacks
Tue, 08/21/12 - 11:40 am
Myriad Genetics
patents
breast cancer
ovarian cancer
Bracanalysis
Novartis drug Afinitor gets EU nod for breast cancer
Reuters
Mon, 07/30/12 - 10:25 am
Afinitor
Novartis
breast cancer
Europe
EntreMed announces initiation of phase 2 trial in triple-negative breast cancer
Yahoo/Fly on the Wall
Wed, 07/25/12 - 09:33 am
EntreMed
triple-negative breast cancer
breast cancer
ENMD-2076
Breast Cancer Halted By Novartis Drug From Easter Island
Bloomberg
Mon, 07/23/12 - 08:50 am
Novartis
Afinitor
breast cancer
Sunshine Biopharma signs Adva-27a manufacturing contract with Beta Pharma
Process and Production
Sat, 07/21/12 - 12:05 pm
Sunshine Biopharma
breast cancer
Beta Pharma
Adva-27a
small cell lung cancer
UPDATE 2-US FDA approves Novartis drug Afinitor for breast cancer
Reuters
Sat, 07/21/12 - 11:51 am
Novartis
Afinitor
breast cancer
Ampio Pharmaceuticals Expands Pipeline with Promising New Cancer Drug NCE001
Motley Fool
Sat, 07/21/12 - 11:42 am
Ampio Pharmaceuticals
NCE001
breast cancer
renal cancer
glioblastoma multiforme
Eisai's Halavan misses endpoints in Phase III trial
Pharma Times, UK
Wed, 07/11/12 - 10:06 am
Eisai
Halavan
Xeloda
breast cancer
NICE turns down Avastin for breast cancer
Fierce Pharma
Fri, 07/6/12 - 11:20 am
Avastin
Roche
breast cancer
NICE
UK
Teva Announces Progress of Biologic Investigational Drugs Evaluated to Treat Neutropenia in Breast Cancer Patients Undergoing Chemotherapy
Pipeline Review
Sat, 06/30/12 - 04:41 pm
Teva Pharmaceuticals
neutropenia
breast cancer
lipegfilgrastim
balugrastim
Novartis' Afinitor recommended by CHMP for EU approval
Yahoo/Fly on the Wall
Fri, 06/22/12 - 09:29 am
Novartis
Afinitor
Europe
CHMP
breast cancer
Protesters push FDA on breast cancer drug at BIO conference
Bizjournals.com
Wed, 06/20/12 - 12:33 pm
FDA
breast cancer
BIO Conference
T-DM1
Immunogen
Roche
PDL's Royalty Agreement with Genentech, and What This Means For Healthcare Stocks
Seeking Alpha
Tue, 06/19/12 - 12:10 pm
breast cancer
PDL Biopharma
Genentech
Roche
Symmetry Medical
Rigel
Medivation
MRI Interventions
BioSante
Horizon Pharma
Pertuzumab
Genentech Eagerly Awaits FDA Word on 2nd Breast Cancer Drug
Xconomy
Fri, 06/8/12 - 11:51 am
FDA
breast cancer
Roche
Perjeta
Pertuzumab
Biotech All Stars Buy Castoff Experimental Merck Cancer Drug
Forbes
Wed, 06/6/12 - 03:30 pm
Merck
Tesaro
niraparib
breast cancer
ovarian cancer
ImmunoGen rises on breast cancer drug data; says Roche plans 3 more T-DM1 studies in 2013
Yahoo/AP
Mon, 06/4/12 - 05:54 pm
Immunogen
Roche
breast cancer
T-DM1
Celegene, Bristol Drugs No Better Than Cheaper Treatments
Bloomberg
Mon, 06/4/12 - 05:41 pm
Celgene
Bristol-Myers Squibb
Ixempra
Abraxane
breast cancer
Study: 'Smart bomb' drug attacks breast cancer
Yahoo/AP
Sun, 06/3/12 - 11:13 am
T-DM1
breast cancer
Genentech
Roche

Pages